XPC and colorectal cancer: An interesting population-based case–control study, including 421 colorectal cancer patients and 845 controls, was conducted in China to assess the association between XPC polymorphisms (Lys939Gln, Ala499Val, and PAT) and colorectal cancer risk [109].